We only have this paper's title and publication details.
Read it at the sourceBill & Melinda Gates Foundation.
No takes yet. Share an insight, caveat, or question.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Although restenosis, patency, and TLR remain important procedural outcomes, patients and clinicians are ultimately concerned with limb preservation, symptom relief, and avoidance of repeat interventions. The SirPAD trial findings demonstrate that the benefits of DCB technology can translate into...”
Kim et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: